期刊文献+

p120蛋白在膀胱非浸润性乳头状尿路上皮癌中表达的研究

Abnormal expression of p120 in non-invasive papillary urothelial carcinoma of human bladder
下载PDF
导出
摘要 目的了解p120在膀胱非浸润性乳头状尿路上皮癌(NPUC)以及浸润性尿路上皮癌(IUC)的表达情况。方法使用HE、免疫组化等方法检测48例膀胱癌标本,28例为膀胱NPUC、20例为IUC,10例为正常膀胱黏膜组织p120、E-cad、p63的表达情况,并结合其病理分级及临床资料进行分析。结果10例正常膀胱黏膜上皮细胞膜p120和E-cad均(+),28例NPUC的异常表达率分别为57%(16/28)和36%(10/28),而IUC均出现两蛋白的异常表达。其中两蛋白在低级别和高级别NPUC的表达差异显著(P<0.01和P<0.05),但与肿瘤大小、患者性别及年龄差异不显著。结论p120在膀胱癌表达异常,有可能成为膀胱NPUC新的标记物,对判断肿瘤预后有参考意义。 Objective To investigate the p120 expression in non-invasive papillary urothelial carcinoma (NPUC) and invasive urothelial carcinoma (IUC) in bladder. Methods We used HE and immuno-histochemical technique to detect the immunoreactivity and cellular localization of p120 and E-cadherin in 48 cases of NPUC and IUC as well as 10 normal bladder biopsies, and correlated these results with pathological and clinical parameters. Resets P120 and E-cadherin were expressed in a normal membranous pattern in all normal bladder epithelium specimens. Loss of normal surface p120 and E-cadherin expression was found in all of IUC, the same results was also detected in NPUC with the expression rates of 16/28 (57%) and 10/ 28 (36%), respectively. Furthermore, there was a significant difference in the membranous expression of p120 and E-cadherin between the low grade NPUC and the high grade NPUC ( P 〈 0.01 and P 〈 0.05), and no obvious relationship was found among the tumor size, age and sex. Conclusion Aberrant expression of p120 may be a new marker of NPUC in bladder, which plays a role in evaluation of the prognosis.
出处 《诊断病理学杂志》 CSCD 2008年第3期216-219,共4页 Chinese Journal of Diagnostic Pathology
基金 广西自然科学基金(桂科自034204) 广西卫生厅课题资助(Z2005075)
关键词 P120 非浸润性乳头状尿路上皮癌 膀胱 p120 Non-invasive papillary urothelial carcinoma Bladder
  • 相关文献

参考文献10

  • 1Strumane K, Bonnomet A, Stove C, et al. E-cadherin regulates human Nanosl, which interacts with pl20ctn and induces tumor cell migration and invasion[Jl. Cancer Res, 2006, 66(20) : 10007 - 10015.
  • 2Fox DT, Peifer M. Cell adhesion: separation of p120's powers[J]? Curr Biol, 2007, 17(1): R24-27.
  • 3Reynolds AB, Roczniak-Ferguson A. Emerging roles for p120-catenin in cell 'adhesion and cancer[J]. Oncogene, 2004, 23(48): 7947- 7956.
  • 4Thoreson MA, Reynolds AB, Reynokls. Altered expression of the catenin p120 in human cancer: implications for tumor progession[J]. Differentiation, 2002, 70(9 - 10) : 583 - 589.
  • 5Sarrio D,Perez-Mies B, Hardisson D, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinomafrom preinvasive to metastatic lesions [ J ]. Oncogene, 2004, 23(19) : 3272 - 3283.
  • 6谢成耀,王亮,刘洋,刘楠,邱雪杉,王恩华.p120^(ctn)在非小细胞肺癌组织中的表达及其临床意义[J].中华病理学杂志,2005,34(4):206-210. 被引量:14
  • 7Moreno-Bueno G, Hardisson D, Sarrio D, et al. Abnormalities of E-and P-cadherin and catenin (beta-, gamma-catenin, and p120 ctn)expression in endometrial cancer and endometrial atypical hyperplasia [J]. J. Pathol, 2003, 199(4): 471-478.
  • 8Kuroiwa K, Konomoto T, Kumazawa J, et al. Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin,alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell careinoma[J]. J Surg Oncol, 2001, 77(2) : 123 - 131.
  • 9LoMuzio L, Pannone G, Staibano S, et al. p120 (cat) delocahzation in cell lines of oral cancer[J]. Oral Oncol, 2002, 38 (1): 64-72.
  • 10van Hengel J, Frans van Roy F. Diverse functions of p120ctn in tumors[J]. Biochim biophys Acta, 2007, 1773( 1 ) : 78 - 88.

二级参考文献14

  • 1Thoreson MA, Anastasiadis PZ, Daniel JM, et al. Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol,2000,148:189-202.
  • 2Mariner DJ, Anastasiadis P, Keilhack H, et al. Identification of Src phosphorylation sites in the catenin p120ctn. J Biol Chem,2001,276:28006-28013.
  • 3Daniel JM, Reynolds AB.The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol,1999,19:3614-3623.
  • 4Bremnes RM, Veve R, Gabrielson E, et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol,2002,20:2417-2428.
  • 5Karayiannakis AJ, Syrigos KN, Alexiou D, et al. Expression patterns of the novel catenin p120cas in gastrointestinal cancers. Anticancer Res,1999,19:4401-4405.
  • 6Gold JS, Reynolds AB, Rimm DL. Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival. Cancer Lett,1998,132:193-201.
  • 7Sarrio D, Perez-Mies B, Hardisson D, et al. Cytoplasmic localization acterize lobular breast carcinoma from of p120ctn and E-cadherin loss charpreinvasive to metastatic lesions. Oncogene, 2004,23:3272-3283.
  • 8Syrigos KN, Karayiannakis A, Syrigou EI, et al. Abnormal expression of p120 correlates with poor survival in patients with bladder cancer. Eur J Cancer,1998,34:2037-2040.
  • 9Noren NK, Liu BP, Burridge K, et al. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol, 2000,150:567-580.
  • 10Jawhari AU, Noda M, Pignatellim M, et al. Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma.J Pathol, 1999,189:180-185.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部